Abatacept is a disease-modifying antirheumatic drug (DMARD) used in the management of rheumatic conditions, such as ...

DRL's management has guided for double-digit growth in FY26, with margins expected to remain similar to FY25 levels. Here's ...

Discover why Dr. Reddy’s Laboratories remains a strong buy amid robust revenue growth, underappreciated pipeline potential, ...

Our team has been researching these complications for over a decade. One major development was the addition of the drug ...

The updated recommendations also provide guidance on antirheumatic drug use through lactation and in male patients trying to ...

Patients who are immunocompromised still can receive a variety of vaccinations based on their specific needs, Cassandra ...

Emkay's latest report downgrades Dr. Reddy's Labs, citing significant margin misses in Q4FY25 despite higher other income and lower tax rates.

John Levine, M.D., a graft-versus-host-disease expert at the Icahn School of Medicine at Mount Sinai in New York, makes a ...

Graft vs. host disease (GVHD) is a serious condition that can occur after a stem cell transplant from a donor, where the ...

Orencia (abatacept) is an FDA-approved medication to help prevent acute GVHD. How graft vs. host disease affects your life may depend on how severe it is and what symptoms you experience.